Related Experiment Video
Updated: May 13, 2026

09:12
Aortic Ring Assay
Published on: November 24, 2009
Pleiotrophin promotes capillary-like sprouting from senescent aortic rings
Sophie Besse1, Romain Comte, Sophie Fréchault
1Laboratoire Croissance Cellulaire, Réparation et Régénération Tissulaires, EAC CNRS 7149, Université Paris-Est, Créteil, France. Sophie.Besse@parisdescartes.fr
Cytokine
|March 14, 2013
Summary
Pleiotrophin (PTN) therapy can restore impaired angiogenesis in aging. This growth factor promotes new blood vessel formation in aged tissues, offering potential therapeutic benefits for age-related conditions.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Aging Research
Background:
- Pleiotrophin (PTN) is a growth factor crucial for angiogenesis, impacting development and tumor growth.
- PTN therapy promotes neovascularization after myocardial infarction.
- Angiogenesis is impaired during aging, necessitating research into restorative therapies.
Purpose of the Study:
- To investigate if Pleiotrophin (PTN) growth factor therapy can restore neovascularization in aged tissues.
- To evaluate the effects of PTN on capillary-like endothelial sprouting in senescent rats.
Main Methods:
- Ex vivo culture of thoracic aortic rings from adult and senescent rats (3 and 24 months old).
- Cultured aortic rings in a 3D collagen matrix with varying concentrations of recombinant human PTN or Vascular Endothelial Growth Factor-165 (VEGF).
- Quantified capillary network length using image analysis at day 3 and 6.
Main Results:
- Capillary-like tube formation was reduced in aged (24 mo) aortic rings compared to younger ones (3 mo).
- PTN significantly increased capillary-like tube formation in a dose-dependent manner in both age groups.
- PTN treatment successfully restored age-associated impaired angiogenesis in senescent aortic segments, comparable to VEGF effects.
Conclusions:
- Pleiotrophin (PTN) effectively induces ex vivo angiogenesis in aged tissues.
- PTN shows promise as a novel therapy for neovascularization in aged individuals.
- Potential applications include treating age-associated ischemia in cardiac, hindlimb, and cerebral tissues.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

